NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)
Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)

NCT07256704

RecruitingNA

Sponsor: Luzerner Kantonsspital

Conditions: Stroke, Traumatic Brain Injury, Multiple Sclerosis

Interventions: Intervention Hypnosis

Countries: Switzerland

This feasibility study investigates the potential of hypnosis as a complementary therapy for improving attentional deficits and reducing fatigue in patients with neurological conditions such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation approaches. By integrating hypnosis with standard care and using EEG to monitor brain activity during hypnosis and sham-hypnosis sessions, this trial aims to evaluate the feasibility, acceptability, and preliminary efficacy of hypnosis in enhancing attention and reducing fatigue.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* ICD-10 Diagnosis of stroke, TBI or MS
* Admitted to the inpatient and/or outpatient in the Clinic for Neurology and Neurorehabilitation
* Age 18 years old or older
* Understanding the German language
* Written informed consent

Exclusion Criteria:

\- Psychiatric disease

Exclusion criteria for the EEG:

\- Scalp or skin conditions that interfere with EEG electrode placement (e.g. open wounds, infections, severe psoriasis) Implanted medical or neurostimulation devices that interfere with EEG electrode placement (e.g. deep brain stimulators, cochlear implants)
Locations (1)
  • Lucerne, Switzerland